We are very excited to share our feature article in Nature Portfolio.

Titled, “Breakthrough Technologies Transform the Discovery and Development of Peptide Drugs.”

The article looks at how Pepticom designs ab initio novel peptide drug candidates using proprietary AI-driven biocomputational software.

You can read the whole article here:

#drugdiscovery #artificialintelligence #drugdiscovery

Skip to content